The search for a vaccine against schistosomiasis - A difficult path but an achievable goal

Immunological Reviews

Volumn 171, Issue , 1999, Pages 149-161

  McManus, Donald Peter ^a  

^a Molecular Parasitology Unit   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; PARASITE ANTIGEN; SCHISTOSOMA VACCINE;

CHINA; HEALTH EDUCATION; HUMAN; IMMUNITY; NONHUMAN; PARASITOSIS; PHILIPPINES; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SANITATION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SEWAGE; WATER SUPPLY;

ANIMALS; FORECASTING; HUMANS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; VACCINES;

EID: 0032743064     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01346.x     Document Type: Review

References (97)

1. 1. Bergquist NR. Controlling schistosomiasis by vaccination: a realistic option? Parasitol Today 1995;11:191-194.
2. 2. Bergquist NR. Schistosomiasis vaccine development: approaches and prospects. Mem Inst Oswaldo Cruz 1995;90:221-227.
3. 3. Dunne DW, et al. Prospects for immunological control of schistosomiasis. Lancet 1995;345:1488-1492.
4. 4. Waine GJ, McManus DP. Schistosomiasis vaccine development - the current picture. Bioessays 1997;19:435-443.
5. 5. Bergquist NR, Colley DG. Schistosomiasis vaccines: research to development. Parasitol Today 1998;14:99-104.
6. 6. Taylor MG, et al. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine 1998;16:1290-1298.
7. 7. Shi Y, Jiang C, Han J, Li Y, Ruppel A. Schistosoma japonicum: an ultraviolet-attenuated cercarial vaccine applicable in the field for water buffaloes. Exp Parasitol 1990;71:100-106.
8. 8. Shi YE, Jiang CF, Han JJ, Li YY, Ruppel A. Immunization of pigs against infection with Schistosoma japonicum using ultraviolet-attenuated cercariae. Parasitology 1993;106:459-462.
9. 9. Mitchell GF. Infection characteristics of Schistosoma japonicum in mice and relevance to the assessment of schistosome vaccines. Adv Parasitol 1991;30:167-200.
10. + T cell response to Schistosoma mansoni. Exp Parasitol 1991;73:110-116.
11. 11. Pearce E. The immunology of schistosomiasis. In: Boothroyd JC, Komuniecki R, eds. Molecular approaches to parasitology. New York: Wiley-Liss; 1995. p. 497-510.
12. 12. Coulson PS. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine. Adv Parasitol 1997;39:272-336.
13. 13. Wilson RA, Coulson PS. Why don't we have a schistosomiasis vaccine? Parasitol Today 1998;14:97-99.
14. 14. Kelly E, Colley DG. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with S. mansoni: reduction of irradiated cercariae-induced resistance. J Immunol 1988;140:2737-2741.
15. + T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128 terminated infections. Immunology 1989;67:266-472.
16. 16. James SL, Sher A. Cell-mediated immune response to schistosomiasis. Curr Top Microbiol Immunol 1990;155:21-41.
17. 17. Osada Y, Chen X, Mohamed RT, Shin E-H, Horie T, Kojima S. The involvement of Th1/2 cytokines in protective immunity against Schistosoma japonicum infection. In: Tada I, Kojima S, Tsuji M, eds. Proceedings of the Ninth International Congress of Parasitology. Bologna, Italy: Monduzzi Editore; 1998. p. 495-502.
18. 18. Smythies LE, Coulson P, Wilson RA . Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 1992;149:3654-3658.
19. 19. Wynn TA, Jankovic D, Hieny S, Cheever A, Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol 1995;154:4701-4709.
20. 20. Wynn TA, et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995;376:594-596.
21. 21. Hoffman KF, Caspar P, Cheever AW, Wynn TA. IFN-γ, IL 12, and TNF α are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J Immunol 1998;161:4201-4210.
22. 22. Caulada-Benedetti Z, Al-Zamel F, Sher A, James S. Comparison of Th1 and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J Immunol 1991;146:1655-1660.
23. 23. Moloney NA, Webbe G. Antibody is responsible for the passive transfer of of immunity to mice from rabbits, rats or mice vaccinated with attenuated S. japonicum cercariae. Parasitology 1990;100:235-239.
24. 24. Dunne DW, Jones FM, Cook L, Moloney NA. Passively transferable protection against Schistosoma japonicum induced in the mouse by multiple vaccination with attenuated larvae: the development of immunity, antibody isotype responses and antigen recognition. Parasite Immunol 1994;16:655-688.
25. 25. Jankovic D, et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell-and IFN-γ-dependent effector mechanisims. J Immunol 1999;162:345-351.
26. 26. Capron M, Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science 1994;264:1876-1877.
27. 27. Capron A, Dessaint JP. Effector and regulatory mechanisims in immunity to schistosomes: a heuristic view. Annu Rev Immunol 1985;3:455-476.
28. 28. Verwaerde C, et al. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. J Immunol 1987;138:4441-4446.
29. 29. Grzych JM, Capron M, Brazin H, Capron A. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. J Immunol 1982;129:2739-2743.
30. 30. Bazin H, Capron A, Capron M, Joseph M, Dessaint JP, Pauwels R. Effect of neonatal injection of anti-μ antibodies on immunity to schistosomes (Schistosoma mansoni) in the rat. J Immunol 1980;124:2373-2377.
31. 31. Kigoni EP, Elsas P, Lenzi HL, Dessein AJ. IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection. Eur J Immunol 1986;16:589-595.
32. 32. Butterworth A. Immunity in human schistosomiasis. Acta Trop Suppl 1987;12:31-40.
33. 33. Wilkins HA, et al. Resistance to reinfection after treatment of urinary schistosomiasis. Trans R Soc Trop Med Hyg 1987;81:29-35.
34. 34. Hagan P, et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-245.
35. 35. Dunne DW, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-1494.
36. 36. Rihet P, et al. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;21:2679-2686.
37. 37. Sturrock R, et al. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Trans R Soc Trop Med Hyg 1983;77:363-371.
38. 38. Hagan P, et al. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol 1985;7:625-632.
39. 39. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. Antigen-specific proliferation and interferon-γ and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis 1998;177:1433-1437.
40. 40. Roberts M, et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993;61:4984-4993.
41. 41. Viana IRC, et al. Interferon-γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg 1994;88:466-470.
42. 42. Medhat A, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998;178:512-519.
43. 43. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins, HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-245.
44. 44. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;21:2679-2686.
45. 45. Dunne DW, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worms and resistance to reinfection. Eur J Immunol 1992;22:1483-1494.
46. 46. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein, AJ. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993;168:1000-1008.
47. 47. Rihet P, Demeure CE, Dessein AJ, Bourgois A. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur J Immunol 1992;22:2063-2070.
48. 48. Gounni AS, et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367:183-186.
49. 49. Abel L, Demenasi F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991;48:959-970.
50. 50. Marquet S, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996;14:181-184.
51. 51. Müller-Myhsok B, et al. Further evidence suggesting the presence of a locus on human chromosome 5q31-q33 influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 1997;61:452-454.
52. 52. Abel L, Dessein AJ. Genetic epidemiology of infectious diseases in humans; design of population-based studies. Emerg Infect Dis 1998;4:1-13.
53. 53. Dessein AJ, et al. Human resistance to schistosomiasis is associated with IgG reactivity to a 37-kDa larval surface antigen. J Immunol 1988;140:2727-2736.
54. 54. Goudot-Crozel V, Caillol D, Djabali M, Dessein AJ. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med 1989;170:2065-2080.
55. 55. Grzych JM, et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J Immunol 1993;150: 527-535.
56. 56. Webster M, et al. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment. Infect Immun 1996;64:4042-4062.
57. 57. Webster M, et al. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology 1997;114:383-393.
58. 58. Santiago ML, et al. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE binding epitopes to allergen peptides. Int Arch Allergy Immunol 1998;117:94-104.
59. 59. Hafalla JCR, et al. Molecular identification of a 21.7 kDa Schistosoma japonicum antigen as a target of the human IgE response. Mol Biochem Parasitol 1999;98:157-161.
60. 60. Li YS, et al. Antibody isotype responses to Schistosoma japonicum infection nine months after the implementation of curative chemotherapy in a community from a marshland area of China. Acta Trop (In press).
61. 61. Waine GJ, Mazzer DR, McManus DP. Production of IgE antibodies against the 22 kDa tegumental membrane associated antigen of schistosomes is directed by the antigen itself. Parasite Immunol 1997;19:531-533.
62. 62. Waine GJ, Becker M, Scott J, Kalinna B, Yang W, McManus DP. Purification of a recombinant Schistosoma japonicum antigen homologous to the 22kDa membrane associated antigen of S. mansoni, a putative vaccine candidate against schistosomiasis. Gene 1994;142:259-263.
63. 63. Waine GJ, Becker M, Yang W, Kalinna B, McManus DP. Cloning, molecular characterisation, and functional activity of Schistosoma japonicum glyceraldehyde 3-phosphate dehydrogenase, a putative vaccine candidate for schistosomiasis. Infect Immun 1993;61:4716-4723.
64. 64. Waine GJ, Becker M, Kalinna B, Yang W, McManus DP. Cloning and functional expression of a Schistosoma japonicum cDNA homologous to the enolase gene family. Biochem Biophys Res Commun 1993;195:1211-1217.
65. c) from the human blood fluke, Schistosoma japonicum. Gene 1994;148:321-325.
66. 66. Becker MM, et al. Gene cloning and complete nucleotide sequence of Philippine Schistosoma japonicum paramyosin. Acta Tropica 1995;59:143-147.
67. 67. Waine GJ, et al. Differential antigen-stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population. Clin Exp Immunol 1998;112:69-73.
68. 68. McManus DP, et al. IL-12 production by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum. Parasitol Int (In press).
69. 69. Moloney NA, Bickle QD, Webbe G. The induction of specific immunity against Schistosoma japonicum by exposure of mice to ultraviolet attenuated cercariae. Parasitology 1985;90:313-323.
70. 70. Bickle QD, Andrews BJ, Doenhoff MJ, Ford MJ, Taylor MG. Resistance against Schistosoma mansoni induced by highly irradiated infections: studies on species specificity of immunization and attempts to transfer resistance. Parasitology 1985;90:301-312.
71. 71. Moloney NA, Garcia EG, Webbe G. The strain specificity of vaccination with ultra violet attenuated cercariae of the Chinese strain of Schistosoma japonicum. Trans Soc Trop Med Hyg 1985;79:245-247.
72. 72. Zhang Y, Taylor MG, Bickle QD, Wang H, Ge J. Vaccination of mice with γ-irradiated Schistosoma japonicum cercariae. Parasite Immunol 1999;21:111-117.
73. 73. Shi Y, Jiang C, Han J, Li Y, Ruppel A. Schistosoma japonicum: an ultraviolet-attenuated cercarial vaccine applicable in the field for water buffaloes. Exp Parasitol 1990;71:100-106.
74. 74. Shi YE, Jiang CF, Han JJ, Li YY, Ruppel A. Immunization of pigs against infection with Schistosoma japonicum using ultraviolet-attenuated cercariae. Parasitology 1993;106:459-462.
75. 75. Tarrab-Hazdai R, Schechtman D, Arnon R. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni. Infect Immun 1998;66:4526-4530.
76. 76. Alarcon J, Waine GW, McManus DP. DNA vaccines: technology and application as anti-parasite and antimicrobial agents. Adv Parasitol 1999;42:343-410.
77. 77. Balloul JM, et al. Molecular cloning of a protective antigen of schistosomes. Nature 1987;326:149-153.
78. 78. Boulanger D, et al. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol 1991;13:473-490.
79. 79. Boulanger D, et al. Vaccine potential of a recombinant glutathione S-transferase cloned from Schistosoma haematobium in primates experimentally infected with an homologous challenge. Vaccine 1999;17:319-326.
80. 80. Liu SX, Song GC, Xu YX, Yang W, McManus DP. Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine 1995;13:603-607.
81. 81. Liu SX, Song GC, Xu YX, Yang W, McManus DP. Anti-fecundity immunity induced in pigs vaccinated with recombinant Schistosoma japonicum 26 kDa glutathione S-transferase. Parasite Immunol 1995;17:335-340.
82. 82. Liu SX, He Y, Song GC, Luo XS, Xu YX, Yang W, McManus DP. Anti-fecundity immunity to Schistosoma japonicum induced in Chinese water buffaloes (Bos buffelus) after vaccination with recomhinant 26 kDa glutathione-S-transferase (re Sjc26GST). Vet Parasitol 1997;69:39-47.
83. 83. Kalinna BH, McManus DP. A vaccine against the Asian schistosome, Schistosoma japonicum: an update on paramyosin as a target of protective immunity. Int J Parasitol 1997;27:1213-1219.
84. 84. Pearce EJ, James SL, Hieny S, Lanar DE, Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci USA 1988;85:5678-5682.
85. 85. Flanigan T, King C, Lett R, Nanduri J, Mahmoud A. Induction of resistance to Schistosoma mansoni infection by mice by purified parasite paramyosin. J Clin Invest 1989;83:1010-1014.
86. 86. Ramirez B, et al. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol 1996;18:49-52.
87. 87. McManus DP, Liu, SX, Song G, Xu Y, Wong JM. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum. Int J Parasitol 1998;28:1739-1742.
88. 88. Kojima S, Nimura M, Kanazawa T. Production and properties of a mouse monoclonal IgE antibody to Schistosoma japonicum. J Immunol 1987;138:2044-2049.
89. 89. Nara T, et al. Demonstration of the target molecule of a protective IgE antibody in secretory glands of Schistosoma japonicum larvae. Int Immunol 1994;6:963-971.
90. 90. Kojima S, Nara T, Osad Y, Chen H, Zhang S, Hirayama K. A vaccine trial for controlling reservoir livestock against schistosomiasis japonica. In: Tada I, Kojima S, Tsuji M, eds. Proceedings of the Ninth International Congress of Parasitology. Bologna, Italy: Monduzzi Editore; 1998. p. 489-494.
91. 91. Kalinna BH, Becker MM, McManus DP. Engineering and expression of a full length cDNA encoding Schistosoma japonicum paramyosin: purification of the recombinant protein and its recognition by infected patient sera. Acta Trop 1997;65:111-115.
92. 92. Wong J, et al. Progress towards a vaccine against schistosomiasis japonica. In: Tada I, Kojima S, Tsuji M, eds. Proceedings of the Ninth International Congress of Parasitology. Bologna, Italy: Monduzzi Editore; 1998, p. 495-502.
93. 93. Ross AGP, et al. Schistosomiasis control in the People's Republic of China. Parasitol Today 1997;13:152-155.
94. 94. Gobert GN, Stenzel DJ, Jones MK, Allen DE, McManus, DP. Schistosoma japonicum; paramyosin immunolocalisation during parasite development. Parasitology 1997;114:45-52.
95. 95. Gobert GN. The role of microscopy in the investigation of paramyosin as a vaccine candidate against Schistosoma japonicum. Parasitol Today 1998;14:115-118.
96. 96. Katz N. Schistosomiasis vaccines: the need for more research before clinical trials. Parasitol Today 1999;15:165-166.
97. 97. Bergquist R, Coley D. Schistosomiasis vaccines: the need for more research before clinical trials. Parasitol Today 1999;15:166-167.